Direct-to-consumer genetic testing market projected to reach $7.19 billion by 2030

From GlobeNewswire: 2025-03-26 09:50:00

The direct-to-consumer genetic testing market is projected to reach $7.19 billion by 2030, with a CAGR of 19.6% from 2022 to 2030. Growth is driven by increasing genetic diseases and public awareness of genetic testing.

Key players in the market include 23andMe, Ancestry, and Helix. Trends include expanding offerings for rare diseases and cancer screening.

Genetic testing is on the rise due to the prevalence of hereditary health conditions. Companies like 23andMe and AncestryDNA offer tests for various diseases, aiding in early detection and personalized healthcare solutions.

North America led the market in 2023, with Asia Pacific expected to show the highest CAGR. The market is segmented by services, modules, therapeutic areas, and end-users.

Direct-to-consumer genetic testing allows customers to access genetic information directly, driving interest in personalized medicine and proactive health management. Companies like AncestryDNA and 23andMe offer tests for various health and wellness insights.



Read more at GlobeNewswire: Direct-to-Consumer Genetic Testing Market Size Set to Reach